Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-768-3 | CAS number: 1285610-71-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Due to the complexity of the skin sensitization process a single in vitro assay is not sufficient to adequately assess this toxicological endpoint. Therefore, a combination of several methods addressing two major steps of the sensitization process: protein reactivity and activation of dendritic cells has been proposed in a strategy to assess the sensitizing potential. To that end, the test substance has been tested in the Direct Pepitde Reactivity Assay (DPRA) and the Dendritic Cell Activation Assay Myeloid U937 Skin Sensitization Test (MUSST). In addition, a third in vitro experiement (Antioxidant response element (ARE) reporter assay) is currently ongoing.
Direct Peptide Reactivity Assay (DPRA)
Chemical reactivity has been shown to be well associated with allergenic potency (Gerberick et al., 2007). Within this context measuring the amount of proteins with nucleophilic side chains such as cysteine or lysine residues after incubation with putative allergens may serve as surrogate markers. The reactivity of the test article towards synthetic cysteine (C)- or lysine (K)-containing peptides was evaluated in the Direct Peptide Reactivity Assay (DPRA). For this purpose the test substance was incubated with synthetic peptides for 24 hours at room temperature and the remaining non-depleted peptide concentration is determined thereafter by high performance liquid chromatography with gradient elution and UV-detection at 220 nm. The peptide depletion of test-substance incubated samples is compared to the peptide depletion of the negative control samples and expressed as relative peptide depletion.
The test substance did not cause depletion of the cysteine-containing peptide. However, depletion of the lysine-containing peptide between 19.4% and 26.5% was observed. In addition co-elution of the test substance with the lysine-containing peptide was noticed. Nevertheless the results are considered to be valid as the three test runs performed with different analytical methods produced comparable values for peptide depletion. Additionally peak purity, determined in the 3rdtest run, demonstrated that the peptide peaks could be integrated correctly.
Based on the observed results and applying the prediction model proposed in Gerberick et. al (2007) it was concluded that the test article shows a low chemical reactivity in the DPRA under the test conditions chosen.
Dendritic Cell Activation Assay Myeloid U937 Skin Sensitization Test (MUSST)
The myeloid U937 skin sensitization test (MUSST) is a dendritic cell activation test to predict skin sensitizing potential. The test is performed using the human pro-monocytic cell line U937 as surrogate for dendritic cells. As readout, the change in the expression of the cell membrane marker CD86 measured by flow cytometry after 48 hours of test substance exposure was determined.
In order to determine the concentrations suitable for the main experiment a pre-test was performed. Cells were exposed to 9 concentrations of the test substance (0.5 μg/mL up to 2000 μg/mL) and cytotoxicity was determined thereafter. The CV75 value (= estimated concentration that affords 75% cell viability) was determined by linear regression from the concentration response curve. In the main test, test substance was used at five final concentrations determined with regard to the CV75 value: CV75 x 2, CV75, CV75/2, CV75/4, CV75/8. A test substance was predicted to have a dendritic cell activating potential when the marker expression exceeded the threshold of 1.2 with respect to vehicle treated cells (VC) at any tested sufficiently oncytotoxic (cell viability ≥ 70%) concentration in at least two independent experiments.
After 48 hours of exposure to test substance CD 86 expression was induced in U937 cells at concentration 24.5 μg/mL affording at least 70% viability (marker induction value was 1.47 in experiment 1 and 1.30 in experiment 3). From this it has to be concluded that test substance does induce dendritic cell activation.
Antioxidant response element (ARE) reporter assay
This assay is currently ongoing and the registration dossier will be updated accordingly upon completion.
Summary
In two in vitro tests the test article gave an indication for a sensitizing potential. Therefore, the test substance has to be classified for skin sensitization.
Migrated from Short description of key information:
The results of an in vitro test battery (DPRA and MUSST assay) suggest a skin sensitization potential for the test article.
Justification for classification or non-classification
The rsults of two in vitro tests give indications for a skin sensitizing potential. Therefore, the test article is classified for skin sensitization in accordance with Directive 67/548/EEC and Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.